Drug-Eluting Stent Payment Should Reflect Patient Complexity – Task Force
This article was originally published in The Gray Sheet
Executive Summary
CMS should create differential drug-eluting stent DRG payment rates based on patient complexity to ensure adequate hospital reimbursement, a Society for Cardiovascular Angiography & Interventions task force report advises
You may also be interested in...
“Appropriate” Defibrillator, Drug-Eluting Stent Payments Pondered By CMS
CMS is seeking comments on ways to structure inpatient payment for implantable cardiac defibrillators so that clinicians will consider using less sophisticated devices in clinically appropriate situations
“Appropriate” Defibrillator, Drug-Eluting Stent Payments Pondered By CMS
CMS is seeking comments on ways to structure inpatient payment for implantable cardiac defibrillators so that clinicians will consider using less sophisticated devices in clinically appropriate situations
Boston Scientific To Study Complex DES Use; Taxus Complaints Surface
Boston Scientific is maintaining a "sober" outlook regarding its chances of obtaining increased reimbursement in the near-term for multi-vessel interventions using drug-eluting stents